Read More

Read More

 

 

BHI INTERNATIONAL SOFT-LANDING PROGRAM

 

BioHealth Innovation’s International Soft-Landing Program assists foreign companies entering the U.S. market with client relationships varying based upon individual company requirements. BHI can assist those seeking US non-dilutive funding through the establish of a US subsidiary in which BHI has minor control (see A below) and/or by providing any of the other support listed in B-G below.  Depending upon the Scope of Work, these services may be offered on a per project/hourly basis with equity sometimes provided in consideration for BHI support.   For more information, email BHI@BioHealth Innovaiton.org

 A. U.S Subsidiary/Corporation Creation

• Create a U.S. corporate entity enabling company to qualify for U.S. federal non-dilutive funding.*
• Ensure international parent maintains ownership of its intellectual property.
• Provide startup management support and/or operating personnel.
• Provide interim U.S corporate office space with desk, mail, receptionist, meeting room services
• Assist in locating appropriate lab, office or other facility space as required.

B. Business Development and Market Analysis

• Assist with the development of corporate strategy, product development and business plans, pitch decks and fundraising narratives.
• Identify potential corporate partners, collaborators, and
• Assist with data/evidence development strategy (i.e. bench, in vitro, preclinical, clinical testing) supporting both market adoption and regulatory requirements.
• Help identify and make introductions to prospective strategic partners, investors, and licensees, and provide advice regarding potential agreements.
• Assist in market sizing and competitor profiling for specific products and services.
• Develop the business case and clinical strategy required for market adoption, sales and marketing.

C. Grant Funding/Non-Dilutive Funding Assistance

• Identify county, state, federal, foundation, and private economic development funding programs that align with company’s product development plans and assist with fulfilling
• Assist with the development of non-dilutive and dilutive grant proposals (i.e. refining project goals, research strategy, budget and cost proposal, program officer and KOL introductions, commercial relevance narrative).

D. Human Resource and General Administration Support

1. Provide support regarding posting US positions via BHI HR function.
2. Facilitate interview process thru use of BHI facilities for Skype conference calls/interviews with prospective candidates.
3. Provide template for HR employee handbook for US personnel (employees, contractors/consultants).
4. Provide advice regarding salary and fringe benefit negotiations.
5. Review media, marketing or printed material in coordination via BHI marketing.
6. Provide mailing address and access to desk space and other amenities. 
7. Provide Executive Administrator and receptionist support including phone, email, and mail. 

E. Marketing and Promotion

1. Assist with product launch/US subsidiary opening and other opportunities for visibility.
2. Provide marketing and branding advice including recommendations regarding online and print publications, industry tradeshows, investment conference and other events.
3. Draft press releases and edit other promotional materials for US target market

F. Pricing and Reimbursement

• Identify product pricing experts to develop relevant pricing models based on relevant research (i.e. product value, payer strategies, competition, willingness to pay).
• Identify reimbursement experts with relevant expertise to develop strategic reimbursement assessments based on pricing research, payer landscaping, medical coding research, etc.

G. Regulatory

• Identify and map potential regulatory pathways for specific products and services.
• Identify appropriate regulatory consultants to create regulatory strategy and support regulatory submissions, filings and correspondence with regulatory agencies.
• Support outreach to governing bodies.
• Support generation of regulatory filings.

H. Resource Identification

• Assist in locating appropriate lab, office or other facility space as required.
• Assist with finding CMOs and/or resources to establish U.S. manufacturing operations.
• Assist with finding CROs and/or related resources (i.e. trials hosts).
• Assist with finding legal, accounting, and other resources to support business growth.

 

 

#    #    #

  

*(BHI’s U.S. soft-landings are structured to enable the new U.S. corporate entity to meet eligibility requirements for Maryland and U.S. federal funding agency small business grant and assistance programs while enabling the international client to control its Intellectual Property. To comply with these eligibility rules, the business must have at least 51% of its ownership held by U.S. citizens and/or permanent resident aliens. (See https://www.sbir.gov/tutorials/program-basics/tutorial-2.). 

Read More

Read More

www.worksourcemontgomery.com

WorkSource Montgomery is the “Go-To” place linking local and regional economic development and workforce efforts by developing a deep understanding of target and emerging industry demands, creating sustainable workforce solutions that are tailored to the region, increasing the ability for individuals to compete for higher-quality jobs and the employers to compete within the marketplace. Most importantly, creating lasting change in Montgomery County’s labor market system.

www.wsgr.com

Wilson Sonsini Goodrich & Rosati is the premier legal adviser to technology, life sciences, and other growth enterprises worldwide. We represent companies at every stage of development, from entrepreneurial start-ups to multi-billion-dollar global corporations, as well as the venture firms, private equity firms, and investment banks that finance and advise them. The firm’s broad range of services and practice areas are focused on addressing the principal challenges faced by the management, boards of directors, shareholders, and in-house counsel of our clients.

To post job/internship opportunities, please email BHI@BioHealthInnovation.org your request with the link/URL to your specific opportunity or to your page highlighting multiple opportunities.  Please also notify us once these position(s) are filled. Thank you.

 

3i Diagnostics, Inc. – Gaithersburg

Advanced BioScience Laboratories, Inc. (ABL) – Rockville

Aledade – Bethesda

Altimmune – Gaithersburg

Amarex Clinical Research – Germantown

American Gene Technologies – Rockville

Aphena – Easton

ARPA-H – Bethesda

AstraZeneca  – Frederick, Gaithersburg

ATCC – Gaithersburg, MD and Manassas, VA

Aurinia Pharmaceuticals – Rockville

Autolus – Gaithersburg, Rockville

b well – Baltimore

BioFactura – Frederick  

Cartesian Therapeutics  –  Gaithersburg

Catalent – Harmans

Champions Oncology, Inc. – Rockville

Children’s National – DC

DrFirst – Rockville

Early Charm – Baltimore

Elixirgen Scientific – Baltimore

Ellume – Frederick

Emergent BioSolutions, Inc. – Baltimore, Gaithersburg, Rockville

EMMES Corp – Frederick, Rockville

Emocha Mobile Health, Inc.  – Baltimore

Frederick National Lab for Cancer Research – Frederick

GetWellNetwork, Inc. – Bethesda

GSK Global Vaccines US R&D Center – Rockville

GlycoMimetics, Inc. – Rockville

Henry Jackson Foundation – Bethesda and Silver Spring, MD

Horizon Therapeutics – Gaithersburg

Immunomic Therapeutics – Rockville

Institute for In Vitro Sciences – Gaithersburg

Intralytix – Baltimore and Columbia

Jecho Laboratories – Frederick

Johns Hopkins Technology Ventures – Baltimore

Johnson & Johnson – DC and Gaithersburg

KeyGene USA – Rockville

Kite Pharma (a Gilead Company) – Frederick, Gaithersburg

Landos Biopharma, Inc. – Reston

Leadiant Biosciences – Gaithersburg

Leidos Biomedical Research – Frederick

Lieber Institute for Brain Development – Baltimore

Lonza – Walkersville

Lupin Pharmaceuticals, Inc. – Baltimore

MacroGenics – Rockville

Maryland Department of Commerce – Baltimore

MaxCyte, Inc. – Gaithersburg

Maxim Biomedical – Rockville

Meso Scale Diagnostics – Rockville, Gaithersburg

Miltenyi Biotec – Gaithersburg

Mimetas – Gaithersburg

National Institutes of Health (NIH) – Bethesda

Netrias– Bethesda and Arlington

NexImmune – Gaithersburg

Nobile Life Sciences – Baltimore

Novavax, Inc. – Gaithersburg, Rockville

Novel MicroDevices – Baltimore

Noxilizer – Baltimore

Precigen – Germantown

Protenus – Baltimore

QIAGEN Sciences – Germantown, Frederick

Quality Biological – Gaithersburg, MD and D.C.  

REGENXBIO Inc. – Rockville

RoosterBio, Inc. – Frederick

Root3Labs – Randallstown

Sanaria, Inc. – Rockville

SeraCare – Gaithersburg

Senseonics – Germantown

Sirnaomics – Gaithersburg

Smith & Nephew – Columbia, MD

SoBran – Bethesda, Baltimore, Poolesville, Silver Spring

Sonavex Surgical, Inc. – Baltimore

Sterilex – Hunt Valley

Supernus Pharmaceuticals – Rockville

ThermoFisher Scientific – Baltimore, Bethesda, Frederick, DC

United Therapeutics – Silver Spring

University of Maryland Medical System – Maryland

U.S. Food and Drug Administration (FDA)

US Pharmacopeia – Rockville

Vaccitech – Maryland

Vanda Pharma – D.C.

Vheda Health – Columbia

WellDoc – Columbia

Westat – Rockville